PlainRecalls
FDA Drug Low Class III Terminated

Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA.

Reported: February 27, 2019 Initiated: February 13, 2019 #D-0513-2019

Product Description

Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA.

Reason for Recall

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Details

Units Affected
44,640 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and b) 100-count (NDC 68180-469-01) bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Goa 403 722 INDIA.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 44,640 bottles.
Why was this product recalled?
CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 27, 2019. Severity: Low. Recall number: D-0513-2019.